Delivery Order SPE2DB24D3013-SPE2DB24FFFSP
- Not listed
- This federal contract award is for the delivery of telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price contract is valued at $1,871.31 and has an ultimate completion date of November 22, 2024. It was awarded on November 21, 2024 as a delivery order, without any set-aside designation. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award is for the delivery of 4,563,681,036 units of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract has a ceiling value of $1,433.08 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through February 16, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
- This federal contract award is for the delivery of Telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $4,277.67 firm fixed-price delivery order contract has an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The federal contract award detailed is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,435.52 with a firm fixed price and a completion date of December 18, 2024. This award is not associated with a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm fixed-price delivery order, valued at $1,866.14, has a period of performance through November 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award, valued at $1,323.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The $2,099.53 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,629.46 and an ultimate completion date of October 30, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the U.S. Department of Defense. The fixed-price, $1,207.68 contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, on October 22, 2024. The contract has an ultimate completion date of October 23, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $5,653.44 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB24FFFSPDelivery Order
This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,021.64 and is a Firm Fixed Price Delivery Order, running through June 7, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 6/6/24 |